Cellular therapies for sickle cell disease: Should we be calling them a cure?

Okoibhole LO, Dasaolu F, Garba-Sani Z, Hibbs SP

Open source

DOI
10.1002/hem3.70283
Published
2025 Dec
Container
HemaSphere
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hem3.70283,
  title = {Cellular therapies for sickle cell disease: Should we be calling them a cure?},
  author = {Okoibhole LO and Dasaolu F and Garba-Sani Z and Hibbs SP},
  year = {2025},
  journal = {HemaSphere},
  doi = {10.1002/hem3.70283},
  url = {https://doi.org/10.1002/hem3.70283}
}

RIS

TY  - JOUR
TI  - Cellular therapies for sickle cell disease: Should we be calling them a cure?
AU  - Okoibhole LO
AU  - Dasaolu F
AU  - Garba-Sani Z
AU  - Hibbs SP
PY  - 2025
JO  - HemaSphere
DO  - 10.1002/hem3.70283
UR  - https://doi.org/10.1002/hem3.70283
ER  - 

APA

LO, O., F, D., Z, G., & SP, H. (2025). Cellular therapies for sickle cell disease: Should we be calling them a cure?. HemaSphere. https://doi.org/10.1002/hem3.70283

Source records